HYBRID EVENT: You can participate in person at Paris, France or Virtually from your home or work.
Lina Chan, Speaker at Dermatology Conferences
University of Nevada Las Vegas School of Medicine, United States
Title : A demonstrative case series on prophylactic treatment of post excised keloids with topical imiquimod



Importance: Keloid excision alone can have recurrence rates approaching 80%.

Objective: To evaluate the clinical use of topical Imiquimod in prophylaxis of keloid regrowth post keloid excision.

Design, Setting, and Participants: Our study is a retrospective case series involving 6 patients with auricular keloid (lobule or helix) present from months to years who were treated at Las Vegas Dermatology from 2006 to 2022.

Results: All 6 patients had normal wound healing post-keloid excision with zero recurrences.

Conclusion and Relevance: Little is known about Imiquimod efficacy for keloid growth prophylaxis. Our study demonstrates that Imiquimod 5% topical applied nightly for six weeks post keloid removal is well tolerated resulting in prophylactic treatment of keloid recurrence.